Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEGIN: FLEX - Insulin Degludec vs Glargine in T2D
NCT01006291Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2009
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
A Phase 3 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Nov 2009; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01006291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006291.